Amyloid-related imaging abnormalities (ARIA) were reported in significant number of patients receiving anti-amyloid immunotherapy for AD, in particular in individuals carrying APOE4 gene allele in a gene dose-dependent manner [308, 309]. The gene discussed is APOE; the disease is Alzheimer disease.